Paul Y. Song
Chief Executive Officer at NKGen Biotech, Inc.
Net worth: 337 204 $ as of 29/04/2024
Profile
Dr. Paul Song is a Chairman & Chief Executive Officer at NKGen Biotech, Inc. and a Chairman & Chief Executive Officer at NKGen Operating Biotech, Inc. He is on the Board of Directors at PeproMene Bio, Inc., Gideons Promise, Inc. and Mercy Corps.
Dr. Song was previously employed as a Chief Executive Officer & Director by Fuse Biotherapeutics, Inc. and a Chief Medical Officer by NKMAX Co., Ltd.
(South korea).
He received his undergraduate degree from The University of Chicago and a doctorate degree from George Washington University School of Medicine & Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.75% | 28/04/2024 | 170,305 ( 0.75% ) | 337 204 $ | 29/04/2024 |
Paul Y. Song active positions
| Companies | Position | Start |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Chief Executive Officer | 09/01/2023 |
PeproMene Bio, Inc.
 PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Director/Board Member | 28/02/2022 |
Mercy Corps
 Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Director/Board Member | - |
| Gideons Promise, Inc. | Director/Board Member | - |
Former positions of Paul Y. Song
| Companies | Position | End |
|---|---|---|
Fuse Biotherapeutics, Inc.
 Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Founder | 31/12/2022 |
| NKMAX CO., LTD. | Chief Tech/Sci/R&D Officer | 31/12/2020 |
Training of Paul Y. Song
| The University of Chicago | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NKMAX CO., LTD. | Health Technology |
| Private companies | 5 |
|---|---|
Mercy Corps
Mercy Corps Services to the Health IndustryHealth Services Mercy Corps provides emergency relief and economic support services. The company makes a real impact in the lives of families in the world’s toughest places. The company was founded by Daninel W. O'Neill and Ellsworth Culver in November 1979 and is headquartered in Portland, OR. | Health Services |
PeproMene Bio, Inc.
PeproMene Bio, Inc. Pharmaceuticals: MajorHealth Technology PeproMene Bio, Inc. engages in developing novel immune-oncology therapies. The company was founded in 2016 and is headquartered in Irvine, CA. | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
Fuse Biotherapeutics, Inc.
Fuse Biotherapeutics, Inc. BiotechnologyHealth Technology Fuse Biotherapeutics, Inc. is a biotechnology company based in Los Angeles, CA. Fuse Biotherapeutics is dedicated to developing transformative immune modulating therapeutics for patients with cancer. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner that targets potent responses to danger without sacrificing natural breaks in the system that spare healthy tissues. The company was founded by Jeffrey Kunio Takimoto, Geoffrey W. Smith, Y Song Paul, Evren Alici, Brian Rabinovich. | Health Technology |
| Gideons Promise, Inc. |
- Stock Market
- Insiders
- Paul Y. Song
